Cargando…

Dexmedetomidine Attenuates Lipopolysaccharide-Induced Sympathetic Activation and Sepsis via Suppressing Superoxide Signaling in Paraventricular Nucleus

Sympathetic overactivity contributes to the pathogenesis of sepsis. The selective α2-adrenergic receptor agonist dexmedetomidine (DEX) is widely used for perioperative sedation and analgesia. We aimed to determine the central roles and mechanisms of DEX in attenuating sympathetic activity and inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Bo, Jin-Hua, Wang, Jing-Xiao, Wang, Xiao-Li, Jiao, Yang, Jiang, Ming, Chen, Jun-Liu, Hao, Wen-Yuan, Chen, Qi, Li, Yue-Hua, Ma, Zheng-Liang, Zhu, Guo-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774688/
https://www.ncbi.nlm.nih.gov/pubmed/36552603
http://dx.doi.org/10.3390/antiox11122395
_version_ 1784855469273120768
author Bo, Jin-Hua
Wang, Jing-Xiao
Wang, Xiao-Li
Jiao, Yang
Jiang, Ming
Chen, Jun-Liu
Hao, Wen-Yuan
Chen, Qi
Li, Yue-Hua
Ma, Zheng-Liang
Zhu, Guo-Qing
author_facet Bo, Jin-Hua
Wang, Jing-Xiao
Wang, Xiao-Li
Jiao, Yang
Jiang, Ming
Chen, Jun-Liu
Hao, Wen-Yuan
Chen, Qi
Li, Yue-Hua
Ma, Zheng-Liang
Zhu, Guo-Qing
author_sort Bo, Jin-Hua
collection PubMed
description Sympathetic overactivity contributes to the pathogenesis of sepsis. The selective α2-adrenergic receptor agonist dexmedetomidine (DEX) is widely used for perioperative sedation and analgesia. We aimed to determine the central roles and mechanisms of DEX in attenuating sympathetic activity and inflammation in sepsis. Sepsis was induced by a single intraperitoneal injection of lipopolysaccharide (LPS) in rats. Effects of DEX were investigated 24 h after injection of LPS. Bilateral microinjection of DEX in the paraventricular nucleus (PVN) attenuated LPS-induced sympathetic overactivity, which was attenuated by the superoxide dismutase inhibitor DETC, cAMP analog db-cAMP or GABA(A) receptor antagonist gabazine. Superoxide scavenger tempol, NADPH oxidase inhibitor apocynin, adenylate cyclase inhibitor SQ22536 or PKA inhibitor Rp-cAMP caused similar effects to DEX in attenuating LPS-induced sympathetic activation. DEX inhibited LPS-induced superoxide and cAMP production, as well as NADPH oxidase, adenylate cyclase and PKA activation. The roles of DEX in reducing superoxide production and NADPH oxidase activation were attenuated by db-cAMP or gabazine. Intravenous infusion of DEX inhibited LPS-induced sympathetic overactivity, NOX activation, superoxide production, TNF-α and IL-1β upregulation in the PVN and plasma, as well as lung and renal injury, which were attenuated by the PVN microinjection of yohimbine and DETC. We conclude that activation of α2-adrenergic receptors with DEX in the PVN attenuated LPS-induced sympathetic overactivity by reducing NADPH oxidase-dependent superoxide production via both inhibiting adenylate cyclase-cAMP-PKA signaling and activating GABA(A) receptors. The inhibition of NADPH oxidase-dependent superoxide production in the PVN partially contributes to the roles of intravenous infusion of DEX in attenuating LPS-induced sympathetic activation, oxidative stress and inflammation.
format Online
Article
Text
id pubmed-9774688
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97746882022-12-23 Dexmedetomidine Attenuates Lipopolysaccharide-Induced Sympathetic Activation and Sepsis via Suppressing Superoxide Signaling in Paraventricular Nucleus Bo, Jin-Hua Wang, Jing-Xiao Wang, Xiao-Li Jiao, Yang Jiang, Ming Chen, Jun-Liu Hao, Wen-Yuan Chen, Qi Li, Yue-Hua Ma, Zheng-Liang Zhu, Guo-Qing Antioxidants (Basel) Article Sympathetic overactivity contributes to the pathogenesis of sepsis. The selective α2-adrenergic receptor agonist dexmedetomidine (DEX) is widely used for perioperative sedation and analgesia. We aimed to determine the central roles and mechanisms of DEX in attenuating sympathetic activity and inflammation in sepsis. Sepsis was induced by a single intraperitoneal injection of lipopolysaccharide (LPS) in rats. Effects of DEX were investigated 24 h after injection of LPS. Bilateral microinjection of DEX in the paraventricular nucleus (PVN) attenuated LPS-induced sympathetic overactivity, which was attenuated by the superoxide dismutase inhibitor DETC, cAMP analog db-cAMP or GABA(A) receptor antagonist gabazine. Superoxide scavenger tempol, NADPH oxidase inhibitor apocynin, adenylate cyclase inhibitor SQ22536 or PKA inhibitor Rp-cAMP caused similar effects to DEX in attenuating LPS-induced sympathetic activation. DEX inhibited LPS-induced superoxide and cAMP production, as well as NADPH oxidase, adenylate cyclase and PKA activation. The roles of DEX in reducing superoxide production and NADPH oxidase activation were attenuated by db-cAMP or gabazine. Intravenous infusion of DEX inhibited LPS-induced sympathetic overactivity, NOX activation, superoxide production, TNF-α and IL-1β upregulation in the PVN and plasma, as well as lung and renal injury, which were attenuated by the PVN microinjection of yohimbine and DETC. We conclude that activation of α2-adrenergic receptors with DEX in the PVN attenuated LPS-induced sympathetic overactivity by reducing NADPH oxidase-dependent superoxide production via both inhibiting adenylate cyclase-cAMP-PKA signaling and activating GABA(A) receptors. The inhibition of NADPH oxidase-dependent superoxide production in the PVN partially contributes to the roles of intravenous infusion of DEX in attenuating LPS-induced sympathetic activation, oxidative stress and inflammation. MDPI 2022-12-02 /pmc/articles/PMC9774688/ /pubmed/36552603 http://dx.doi.org/10.3390/antiox11122395 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bo, Jin-Hua
Wang, Jing-Xiao
Wang, Xiao-Li
Jiao, Yang
Jiang, Ming
Chen, Jun-Liu
Hao, Wen-Yuan
Chen, Qi
Li, Yue-Hua
Ma, Zheng-Liang
Zhu, Guo-Qing
Dexmedetomidine Attenuates Lipopolysaccharide-Induced Sympathetic Activation and Sepsis via Suppressing Superoxide Signaling in Paraventricular Nucleus
title Dexmedetomidine Attenuates Lipopolysaccharide-Induced Sympathetic Activation and Sepsis via Suppressing Superoxide Signaling in Paraventricular Nucleus
title_full Dexmedetomidine Attenuates Lipopolysaccharide-Induced Sympathetic Activation and Sepsis via Suppressing Superoxide Signaling in Paraventricular Nucleus
title_fullStr Dexmedetomidine Attenuates Lipopolysaccharide-Induced Sympathetic Activation and Sepsis via Suppressing Superoxide Signaling in Paraventricular Nucleus
title_full_unstemmed Dexmedetomidine Attenuates Lipopolysaccharide-Induced Sympathetic Activation and Sepsis via Suppressing Superoxide Signaling in Paraventricular Nucleus
title_short Dexmedetomidine Attenuates Lipopolysaccharide-Induced Sympathetic Activation and Sepsis via Suppressing Superoxide Signaling in Paraventricular Nucleus
title_sort dexmedetomidine attenuates lipopolysaccharide-induced sympathetic activation and sepsis via suppressing superoxide signaling in paraventricular nucleus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774688/
https://www.ncbi.nlm.nih.gov/pubmed/36552603
http://dx.doi.org/10.3390/antiox11122395
work_keys_str_mv AT bojinhua dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT wangjingxiao dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT wangxiaoli dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT jiaoyang dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT jiangming dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT chenjunliu dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT haowenyuan dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT chenqi dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT liyuehua dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT mazhengliang dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus
AT zhuguoqing dexmedetomidineattenuateslipopolysaccharideinducedsympatheticactivationandsepsisviasuppressingsuperoxidesignalinginparaventricularnucleus